These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34020529)

  • 1. A case report of simultaneous medullary and papillary carcinoma of thyroid.
    Ziaolhagh R; Sadrizadeh A; Shabany BP; Roudi AA
    Endocr Regul; 2021 May; 55(2):83-88. PubMed ID: 34020529
    [No Abstract]   [Full Text] [Related]  

  • 2. Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.
    Fibbi B; Pinzani P; Salvianti F; Rossi M; Petrone L; De Feo ML; Panconesi R; Vezzosi V; Bianchi S; Simontacchi G; Mangoni M; Pertici M; Forti G; Pupilli C
    Endocr Pathol; 2014 Sep; 25(3):324-31. PubMed ID: 24858900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature.
    Rossi S; Fugazzola L; De Pasquale L; Braidotti P; Cirello V; Beck-Peccoz P; Bosari S; Bastagli A
    Endocr Relat Cancer; 2005 Jun; 12(2):281-9. PubMed ID: 15947103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous metastatic medullary and papillary thyroid carcinomas in a patient with germline RET mutation: case report, molecular analysis, and implications for pathogenesis.
    Griffith C; Zhang S; Mukhopadhyay S
    Endocr Pathol; 2010 Jun; 21(2):115-9. PubMed ID: 20369307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.
    Ciampi R; Romei C; Pieruzzi L; Tacito A; Molinaro E; Agate L; Bottici V; Casella F; Ugolini C; Materazzi G; Basolo F; Elisei R
    J Endocrinol Invest; 2017 Jan; 40(1):55-62. PubMed ID: 27535135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.
    Rendl G; Rodrigues M; Schweighofer-Zwink G; Hutter J; Hittmair A; Zellinger B; Hauser-Kronberger C; Pirich C
    Wien Klin Wochenschr; 2017 Aug; 129(15-16):540-544. PubMed ID: 28493027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous occurrence of papillary thyroid carcinoma, medullary thyroid carcinoma, and lymphoma: A case report.
    Hao Z; Cui H; Li Y; Wu W; Wang Y; Dan H; Lou L; Wang H; Zhao P
    Medicine (Baltimore); 2024 Aug; 103(33):e39363. PubMed ID: 39151514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermixed medullary and papillary thyroid cancer in a patient with renal cell carcinoma.
    Samarasinghe S; Yuksel S; Mehrotra S
    Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32538376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Hodgkin lymphoma and BRAFV600E-positive papillary thyroid carcinoma: A case report.
    Liu S; Zhao Y; Li M; Xi J; Shi B; Zhu H
    Medicine (Baltimore); 2019 Jan; 98(3):e14180. PubMed ID: 30653166
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
    Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
    [No Abstract]   [Full Text] [Related]  

  • 11. Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior.
    Biscolla RP; Ugolini C; Sculli M; Bottici V; Castagna MG; Romei C; Cosci B; Molinaro E; Faviana P; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
    Thyroid; 2004 Nov; 14(11):946-52. PubMed ID: 15671773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review.
    Fallahi P; Patrizio A; Stoppini G; Elia G; Ragusa F; Paparo SR; Balestri E; Mazzi V; Botrini C; Varricchi G; Ulisse S; Ghionzoli M; Antonelli A; Ferrari SM
    Curr Oncol; 2023 Nov; 30(12):10237-10248. PubMed ID: 38132379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation.
    Papi G; Corrado S; Pomponi MG; Carapezzi C; Cesinaro A; LiVolsi VA
    Endocr Pathol; 2003; 14(3):269-76. PubMed ID: 14586073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
    Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review.
    A Al Hamad M; Albisher HM; Al Saeed WR; Almumtin AT; Allabbad FM; A Shawarby M
    BMC Cancer; 2019 Feb; 19(1):170. PubMed ID: 30795755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.
    Goutas N; Vlachodimitropoulos D; Bouka M; Lazaris AC; Nasioulas G; Gazouli M
    Anticancer Res; 2008; 28(1A):305-8. PubMed ID: 18383861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigenerational familial medullary thyroid cancer (FMTC): evidence for FMTC phenocopies and association with papillary thyroid cancer.
    Fugazzola L; Cerutti N; Mannavola D; Ghilardi G; Alberti L; Romoli R; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):53-63. PubMed ID: 11849247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability.
    Colombo C; Muzza M; Proverbio MC; Tosi D; Soranna D; Pesenti C; Rossi S; Cirello V; De Leo S; Fusco N; Miozzo M; Bulfamante G; Vicentini L; Ferrero S; Zambon A; Tabano S; Fugazzola L
    Thyroid; 2019 Feb; 29(2):237-251. PubMed ID: 30501571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management--A Case Report.
    Shrestha RT; Karunamurthy A; Amin K; Nikiforov YE; Caramori ML
    Thyroid; 2015 Dec; 25(12):1375-8. PubMed ID: 26355276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.